| The pro‐inflammatory environment in recalcitrant diabetic foot wounds JB Acosta, D Garcia del Barco, D Cibrian Vera, W Savigne, ... International wound journal 5 (4), 530-539, 2008 | 227 | 2008 |
| A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: report of a pilot clinical trial G Gonzalez, T Crombet, M Catala, V Mirabal, JC Hernandez, Y González, ... Annals of oncology 9 (4), 431-435, 1998 | 195 | 1998 |
| Epidermal growth factor in clinical practice–a review of its biological actions, clinical indications and safety implications J Berlanga‐Acosta, J Gavilondo‐Cowley, P López‐Saura, ... International wound journal 6 (5), 331-346, 2009 | 183 | 2009 |
| A recombinant fusion protein containing the domain III of the dengue-2 envelope protein is immunogenic and protective in nonhuman primates L Hermida, L Bernardo, J Martín, M Alvarez, I Prado, C López, BC Sierra, ... Vaccine 24 (16), 3165-3171, 2006 | 152 | 2006 |
| Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing J Berlanga-Acosta, GS Schultz, E López-Mola, G Guillen-Nieto, ... BioMed research international 2013, 2013 | 147 | 2013 |
| Domain III of the envelope protein as a dengue vaccine target MG Guzman, L Hermida, L Bernardo, R Ramirez, G Guillén Expert review of vaccines 9 (2), 137-147, 2010 | 144 | 2010 |
| Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B … JC Aguilar, Y Lobaina, V Muzio, D Garcia, E Penton, E Iglesias, ... Immunology and cell biology 82 (5), 539-546, 2004 | 132 | 2004 |
| Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds JB Acosta, W Savigne, C Valdez, N Franco, JS Alba, A Rio, ... International wound journal 3 (3), 232-239, 2006 | 113 | 2006 |
| C-Phycocyanin is neuroprotective against global cerebral ischemia/reperfusion injury in gerbils G Pentón-Rol, J Marín-Prida, G Pardo-Andreu, G Martínez-Sánchez, ... Brain research bulletin 86 (1-2), 42-52, 2011 | 112 | 2011 |
| Immune response to synthetic peptides of dengue prM protein S Vázquez, MG Guzmán, G Guillen, G Chinea, AB Pérez, M Pupo, ... Vaccine 20 (13-14), 1823-1830, 2002 | 111 | 2002 |
| Type I interferon signals in macrophages and dendritic cells control dengue virus infection: implications for a new mouse model to test dengue vaccines R Züst, YX Toh, I Valdés, D Cerny, J Heinrich, L Hermida, E Marcos, ... Journal of virology 88 (13), 7276-7285, 2014 | 110 | 2014 |
| Treatment of chronic hepatitis B naïve patients with a therapeutic vaccine containing HBs and HBc antigens (a randomized, open and treatment controlled phase III clinical trial) M Al Mahtab, SMF Akbar, JC Aguilar, G Guillen, E Penton, A Tuero, ... PLoS One 13 (8), e0201236, 2018 | 94 | 2018 |
| Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome J Berlanga-Acosta, J Fernández-Montequín, C Valdés-Pérez, ... BioMed research international 2017, 2017 | 89 | 2017 |
| Outer membrane vesicles of the VA‐MENGOC‐BC® vaccine against serogroup B of Neisseria meningitidis: Analysis of protein components by two‐dimensional … L Uli, L Castellanos‐Serra, L Betancourt, F Domínguez, R Barberá, ... Proteomics 6 (11), 3389-3399, 2006 | 88 | 2006 |
| Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates L Bernardo, A Izquierdo, M Alvarez, D Rosario, I Prado, C López, ... Antiviral research 80 (2), 194-199, 2008 | 86 | 2008 |
| A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice I Valdés, L Bernardo, L Gil, A Pavón, L Lazo, C López, Y Romero, ... Virology 394 (2), 249-258, 2009 | 84 | 2009 |
| C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells G Pentón-Rol, G Martínez-Sánchez, M Cervantes-Llanos, ... International immunopharmacology 11 (1), 29-38, 2011 | 83 | 2011 |
| A dengue-2 Envelope fragment inserted within the structure of the P64k meningococcal protein carrier enables a functional immune response against the virus in mice L Hermida, R Rodrı́guez, L Lazo, R Silva, A Zulueta, G Chinea, C López, ... Journal of virological methods 115 (1), 41-49, 2004 | 75 | 2004 |
| Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein … GGN MARÍA, R Rodriguez, R Rodriguez, L Hermida, M Alvarez, L LAURA, ... Am. J. Trop. Med. Hyg 69 (2), 129-134, 2003 | 75 | 2003 |
| A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus L Lazo, L Hermida, A Zulueta, J Sánchez, C López, R Silva, G Guillén, ... Vaccine 25 (6), 1064-1070, 2007 | 69 | 2007 |
